Skip to main content

Table 2 Risk estimate of P. falciparum clearance at day 1, G6PD deficiency genotypes versus G6PD-normal

From: Plasmodium falciparum clearance with artemisinin-based combination therapy (ACT) in patients with glucose-6-phosphate dehydrogenase deficiency in Mali

  n OR (95% IC) P
Genotypes of G6PD    
Homozygous 3 0.894 (0.079-10.12) 0.93
Hemizygous 22 0.842 (0.33-2.15) 0.72
Heterozygous 31 0.695 (0.303-1.59) 0.40
Normal 258 1 (Reference)